Pyxis Oncology, Inc. — Director's Dealing 2023

Sep 27, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pyxis Oncology, Inc. (PYXS)
CIK: 0001782223
Period of Report: 2023-09-22

Reporting Person: Dupont Jakob (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-09-22	Stock Option (Right to Buy)	$1.60	A	392461	Acquired	2033-09-22	Common Stock (392461)	Direct

Footnotes

F1: These stock options vest in three equal annual installments beginning on the first anniversary of August 23, 2023, subject to the reporting person's continued service through the applicable vesting date.